A study led by E. Dale Abel, MD, PhD, suggests that blocking glucose metabolism in platelets might provide a target for reducing abnormal blood clotting in patients with diabetes.
News
We often hear about research behind the principles that we learned during the first two years of our medical school education. However, we often hear that some ideas have yet to be elucidated. For medical students, these are great opportunities for us to contribute to medical knowledge.
It’s more than a coincidence that a handful of researchers from Harvard recently migrated to the University of Iowa. They’re drawn by the Iowa Neuroscience Institute and its collaborative environment and support for young investigators.
Get to know current PhD student Jennie Liu and what she is accomplishing at the University of Iowa.
An international team of scientists, including University of Iowa biophysicist Chris Ahern, PhD, used a lethal scorpion toxin to capture detailed, 3D pictures of a protein involved in pain.
The 3:30 p.m. ceremony honors three faculty from the Department of Ophthalmology and Visual Sciences—Mark Greiner, MD; Erin Shriver, MD, FACS; and Matthew Thurtell, MBBS, MSc—who will hold new endowed professorships.
Similarities between two sudden death syndromes—SIDS and SUDEP—have University of Iowa neuroscientists looking for common causes that might help improve care and save lives.
A new study, led by UI immunologist Patrick Schlievert, PhD, identifies a single molecule as a key entry point used by two types of dangerous bacteria to break through cellular barriers and cause disease.
Potential new cystic fibrosis treatment uses “molecular prosthetic” for missing lung protein.
University of Iowa Holden Comprehensive Cancer Center is the first U.S. cancer center to be designated a Neuroendocrine Tumor Center of Excellence by the European Neuroendocrine Tumor Society (ENETS).